Madrid Ana María, Defilippi C Carlos, Defilippi G Claudia, Slimming A Jocelyn, Quera P Rodrigo
Departamento de Medicina, Sección Gastroenterología, Hospital Clínico, Universidad de Chile, Santiago, Chile.
Rev Med Chil. 2007 Oct;135(10):1245-52. Epub 2007 Dec 20.
Recent studies have described a high percentage of small intestinal bacterial overgrowth (SIBO) in patients with irritable bowel syndrome (IBS). However, the prevalence of SIBO has not been well established in other functional disorders.
To evaluate the prevalence of SIBO in patients with different functional gastrointestinal disorders (FGID).
Patients with FGID completed a self-administered questionnaire providing information to diagnose functional disorders on the basis of Rome II criteria. SIBO was assessed using a standardized lactulose breath test. A basal value of breath hydrogen (H2) >20 ppm and/or two lectures of HZ values >20 ppm during the first 60 minutes were considered suggestive of SIBO.
We studied 367 patients with a mean age of 50 years (87% females). Of these, 225 had IBS (45 constipation predominant, 121 diarrhea predominant and 59 alternating type), 33 had functional constipation, 83 had functional bloating and 26 had functional diarrhea. SIBO was found in 76% of patients with IBS, 73% of those with functional constipation, 69% of those with functional diarrhea and 68% of those with functional bloating.
This study confirms a high percentage of SIBO in patients with IBS and other FGID. The eradication of SIBO should be considered as a therapeutic tool in these patients.
近期研究表明,肠易激综合征(IBS)患者中小肠细菌过度生长(SIBO)的比例很高。然而,SIBO在其他功能性疾病中的患病率尚未明确。
评估不同功能性胃肠疾病(FGID)患者中SIBO的患病率。
FGID患者完成一份自我管理的问卷,根据罗马II标准提供诊断功能性疾病的信息。使用标准化乳果糖呼气试验评估SIBO。呼气氢气(H2)基础值>20 ppm和/或最初60分钟内两次H2值>20 ppm被认为提示SIBO。
我们研究了367例患者,平均年龄50岁(87%为女性)。其中,225例患有IBS(45例以便秘为主,121例以腹泻为主,59例为交替型),33例患有功能性便秘,83例患有功能性腹胀,26例患有功能性腹泻。IBS患者中76%、功能性便秘患者中73%、功能性腹泻患者中69%以及功能性腹胀患者中68%存在SIBO。
本研究证实IBS和其他FGID患者中SIBO的比例很高。在这些患者中,应考虑将根除SIBO作为一种治疗手段。